Collaco JM, McGrath-Morrow SA. Respiratory phenotypes for preterm infants, children, and adults: bronchopulmonary dysplasia and more. Ann Am Thorac Soc. 2018;15(5):530–8.

Article  PubMed  Google Scholar 

Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019;200(6):751–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol. 2014;100(3):145–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siffel C, Hirst AK, Sarda SP, Chen H, Ferber J, Kuzniewicz MW, et al. The clinical burden of extremely preterm birth in a large medical records database in the United States: complications, medication use, and healthcare resource utilization. J Matern Fetal Neonatal Med. 2022;35(26):10271–8.

Article  PubMed  Google Scholar 

Lai KC, Lorch SA. healthcare costs of major morbidities associated with prematurity in US children’s hospitals. J Pediatr. 2023;256:53-62.e4.

Article  PubMed  Google Scholar 

Houben E, Siffel C, Overbeek J, Penning-van Beest F, Niklas V, Sarda SP. Respiratory morbidity, healthcare resource use, and cost burden associated with extremely preterm birth in The Netherlands. J Med Econ. 2021;24(1):1290–8.

Article  PubMed  Google Scholar 

Prenzel F, Vogel M, Siekmeyer W, Körner A, Kiess W, Vom Hove M. Exercise capacity in children with bronchopulmonary dysplasia at school age. Respir Med. 2020;171:106102.

Article  PubMed  Google Scholar 

Meijer-Schaap L, Dubois AEJ, Kollen BJ, Tijmens-van der Hulst J, Flokstra-de Blok BMJ, Vrijlandt EJLE. Development and construct validation of a parent-proxy quality of life instrument in children with bronchopulmonary dysplasia aged 4–8 years old. Qual Life Res. 2019;28(2):523–33.

Bell EF, Hintz SR, Hansen NI, Bann CM, Wyckoff MH, DeMauro SB, et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013–2018. JAMA. 2022;327(3):248–63.

Article  PubMed  Google Scholar 

Nakashima T, Inoue H, Sakemi Y, Ochiai M, Yamashita H, Ohga S, et al. trends in bronchopulmonary dysplasia among extremely preterm infants in Japan, 2003–2016. J Pediatr. 2021;230:119-25.e7.

Article  PubMed  Google Scholar 

Lui K, Vento M, Modi N, Kusuda S, Lehtonen L, Håkansson S, et al. Inter-center variability in neonatal outcomes of preterm infants: a longitudinal evaluation of 298 neonatal units in 11 countries. Semin Fetal Neonatal Med. 2021;26(1):101196.

Article  PubMed  Google Scholar 

Gilfillan M, Bhandari V. Pulmonary phenotypes of bronchopulmonary dysplasia in the preterm infant. Semin Perinatol. 2023;47:151810.

Article  PubMed  Google Scholar 

Steinhorn R, Davis JM, Göpel W, Jobe A, Abman S, Laughon M, et al. Chronic pulmonary insufficiency of prematurity: developing optimal endpoints for drug development. J Pediatr. 2017;191:15-21.e1.

Article  PubMed  Google Scholar 

Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112–21.

Article  CAS  PubMed  Google Scholar 

Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 1999;340(25):1962–8.

Article  CAS  PubMed  Google Scholar 

Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, et al. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet. 2016;387(10030):1827–36.

Article  CAS  PubMed  Google Scholar 

Doyle LW, Cheong JL, Hay S, Manley BJ, Halliday HL. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2021;11(11):CD001145.

PubMed  Google Scholar 

Hwang JK, Shin SH, Kim EK, Kim SH, Kim HS. Association of newer definitions of bronchopulmonary dysplasia with pulmonary hypertension and long-term outcomes. Front Pediatr. 2023;11:1108925.

Article  PubMed  PubMed Central  Google Scholar 

Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276(7):357–68.

Article  PubMed  Google Scholar 

Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29(7):710–7.

Article  CAS  PubMed  Google Scholar 

De Paepe ME, Mao Q, Powell J, Rubin SE, DeKoninck P, Appel N, et al. Growth of pulmonary microvasculature in ventilated preterm infants. Am J Respir Crit Care Med. 2006;173(2):204–11.

Article  PubMed  Google Scholar 

Bland RD, Albertine KH, Carlton DP, Kullama L, Davis P, Cho SC, et al. Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res. 2000;48(1):64–74.

Article  CAS  PubMed  Google Scholar 

Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999;46(6):641–3.

Article  CAS  PubMed  Google Scholar 

Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho SC, et al. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med. 1999;159(3):945–58.

Article  CAS  PubMed  Google Scholar 

Shepherd EG, Clouse BJ, Hasenstab KA, Sitaram S, Malleske DT, Nelin LD, et al. Infant pulmonary function testing and phenotypes in severe bronchopulmonary dysplasia. Pediatrics. 2018;141(5):e20173350.

Article  PubMed  Google Scholar 

Collaco JM, McGrath-Morrow SA. Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life. Pediatr Pulmonol. 2021;56(11):3464-71.

Cousins M, Hart K, Kotecha SJ, Henderson AJ, Watkins WJ, Bush A, et al. Characterising airway obstructive, dysanaptic and PRISm phenotypes of prematurity-associated lung disease. Thorax. 2023;78(9):896-903.

Hysinger EB. Central airway issues in bronchopulmonary dysplasia. Pediatr Pulmonol. 2021;56(11):3518-26.

Hysinger E, Friedman N, Jensen E, Zhang H, Piccione J. Bronchoscopy in neonates with severe bronchopulmonary dysplasia in the NICU. J Perinatol. 2019;39(2):263–8.

Article  CAS  PubMed  Google Scholar 

Hysinger EB, Friedman NL, Padula MA, Shinohara RT, Zhang H, Panitch HB, et al. Tracheobronchomalacia is associated with increased morbidity in bronchopulmonary dysplasia. Ann Am Thorac Soc. 2017;14(9):1428-35.

Wu KY, Jensen EA, White AM, Wang Y, Biko DM, Nilan K, et al. Characterization of disease phenotype in very preterm infants with severe bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2020;201(11):1398-1406.

Hart K, Cousins M, Watkins WJ, Kotecha SJ, Henderson AJ, Kotecha S. Association of early-life factors with prematurity-associated lung disease: prospective cohort study. Eur Respir J. 2022;59(5):2101766.

Taylor JB, Nyp MF, Norberg M, Dai H, Escobar H, Ellerbeck E, et al. Impact of intercurrent respiratory infections on lung health in infants born < 29 weeks with bronchopulmonary dysplasia. J Perinatol. 2014;34(3):223–8.

Article  CAS  PubMed  Google Scholar 

Deschamps J, Boucekine M, Fayol L, Dubus JC, Nauleau S, Garcia P, et al. Neighborhood disadvantage and early respiratory outcomes in very preterm infants with bronchopulmonary dysplasia. J Pediatr. 2021;237:177-82.e1.

Article  PubMed  Google Scholar 

Banwell E, Collaco JM, Oates GR, Rice JL, Juarez LD, Young LR, et al. Area deprivation and respiratory morbidities in children with bronchopulmonary dysplasia. Pediatr Pulmonol. 2022;57(9):2053–9.

Article  PubMed  PubMed Central  Google Scholar 

Collaco JM, Morrow M, Rice JL, McGrath-Morrow SA. Impact of road proximity on infants and children with bronchopulmonary dysplasia. Pediatr Pulmonol. 2020;55(2):369–75.

Article  PubMed  Google Scholar 

Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 2006;117(6):1901–6.

Article  PubMed  Google Scholar 

Greenberg RG, McDonald SA, Laughon MM, Tanaka D, Jensen E, Van Meurs K, et al. Online clinical tool to estimate risk of bronchopulmonary dysplasia in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed. 2022 Jun 21:fetalneonatal-2021-323573. Online ahead of print.

Balany J, Bhandari V. Understanding the impact of infection, inflammation, and their persistence in the pathogenesis of bronchopulmonary dysplasia. Front Med (Lausanne). 2015;2:90.

PubMed  PubMed Central  Google Scholar 

Rippa AL, Alpeeva EV, Vasiliev AV, Vorote